Nov 4, 2024, 12:24
Julian Downward: Mechanisms limiting responses of KRAS mutant lung cancer to KRAS inhibitors and immunotherapy
Julian Downward, Cancer biologist at the Francis Crick Institute, shared on X:
“In our new paper just out in Science Advances we investigate mechanisms that may be limiting responses of KRAS mutant lung cancer to KRAS inhibitors and immunotherapy.”
Authors: Megan Cole, Panayiotis Anastasiou, Claudia Lee, Xiaofei Yu, Andrea De Castro, Jannes Roelink, Chris Moore, Edurne Mugarza, Martin Jones, Karishma Valand, Sareena Rana, Emma Colliver, Mihaela Angelova, Katey S. S. Enfield, Alastair Magness, Asher Mullokandov, Gavin Kelly, Tanja D. De Gruijl, Miriam Molina-Arcas, Charles Swanton, Julian Downward, Febe Van Maldeghem.
Alastair Magness
Andrea De Castro
Asher Mullokandov
cancer
Charles Swanton
Chris Moore
Claudia Lee
Edurne Mugarza
Emma Colliver
Febe Van Maldeghem
Gavin Kelly
Jannes Roelink
Julian Downward
Karishma Valand
Katey S. S. Enfield
Martin Jones
Megan Cole
Mihaela Angelova
Miriam Molina-Arcas
OncoDaily
Oncology
Panayiotis Anastasiou
Sareena Rana
Tanja D. De Gruijl
Xiaofei Yu
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12